Barchart on MSN
Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly ...
The Healthy @Reader's Digest on MSN
More Than 23,000 Bottles of a Popular Antihistamine Have Been Recalled Nationwide
If you fight fall allergies with this possible swap for Zyrtec, Claritin, or Allegra, the FDA warns it's been recalled due to ...
The dexamethasone insert effectively treats postoperative inflammation and allergic conjunctivitis, with a favorable safety ...
Chic n Savvy on MSN
10 CVS finds under $5 that beat name brands
Saving money doesn’t always mean giving up on quality. In fact, some of the cheapest finds at CVS are nearly identical to the ...
I read your recent column where you said that ivermectin has not been proven to be an effective treatment for cancer. I feel ...
I am a healthy 69-year-old female. I walk every day and belong to an exercise group that I attend twice a week. I’m writing ...
The Supreme Court has given the go-ahead to Natco Pharma for launching its generic version of Risdiplam in India, dismissing the appeal filed by Swiss drugmaker F. Hoffmann-La Roche ...
While the Disrupt stages lead the discussion on tech’s future, Side Events keep it going. Think of them as bonus forums for connection — panels, workshops, and socials designed to spark collaboration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback